Inside Acesis’ Solution to Low Testosterone: Mission, Market, and Momentum
We’ll break down the company’s current pitch deck and raise offering, highlighting key points around the problem, solution, market potential, and early traction.
May 22nd at 1:30pm PST
A Pioneering Discovery
Dr. Papadopoulos of Acesis discovered a novel steroid biosynthesis mechanism, revealing key regulators of mitochondrial cholesterol as a target for new drug design.
This discovery led to two families of patents owned by Acesis and set the course for a fantastic investor opportunity.
Our non-steroidal oral therapy is set to transform men's healthcare.
How does it work? It helps the body produce its own testosterone, in contrast to traditional testosterone replacement therapies, which have known side effects.
There is nothing else like it on the market.
Register Now to get a transparent look at Acesis' vision, strategy, and investment opportunity.
©2025 Acesis Biomed. All rights reserved.